Skip to content

Ducol Organics And Colours Ltd. (DUCOL)

SME Cap

Industrials stocks · SME cap · NSE

Ducol Organics and Colours Ltd. manufactures pigment dispersions. It has expanded into non-pigment dispersions, waterproofing, and construction chemicals through strategic acquisitions like Bitumag Industries and Xchem Polymers. The company has 6 manufacturing facilities and exports to over 30 countries, leveraging R&D and strategic partnerships for global reach.

₹124
+2.50 · +2.06%
Market cap ₹219 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result20 May, 10:11 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

48Neutral

SMA20 +12.6% / mo · MACD −

Stock trend: 50
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

DUCOLD candles · FIT view+0.1%
Latest close ₹124.00 on 2026-10-21
Bar
-0.8%
RSI
53
MACD hist
-0.52
52W pos
28%
Visible chart range
Candle interval
2026-10-21O ₹125.00H ₹125.00L ₹124.00C ₹124.00Vol 8,800 sh
₹98.45₹106.98₹115.50₹124.03₹132.55₹124.00VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

DUCOLNifty India ManufacturingNifty 500
-11%+1%+12%+23%21 Jul2 Sept21 Oct21 Oct 2026DUCOL +14.3%Nifty India Manufactu… -7.7%Nifty 500 -6.5%
DUCOL
+14.3%
Nifty 500
-6.5%
Nifty India Manufacturing
-7.7%
Vs Nifty 500
+20.8 pp
Chart stats
21 Oct 2026
From 52W high
-40.8%
₹209.5
52W range position
28%
₹90 - ₹209.5
ATR (14)
4.3%
₹5.4
Volume vs 20D
0.86x
Latest completed session
Avg traded value
₹0.1 Cr
20-session average
20D price channel
₹115 - ₹131
66.0% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is mixed.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · WATCHLIST
33

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Pending data
—

Revenue NDF · PAT NDF YoY

Technical
Neutral
48

Price trend and sector-relative-strength timing.

Valuation
Legacy model
+29.1%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
55

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Pending data

YoY comparison unavailable - result verdict pending data

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹72 CrNDF+10.8%
EBITDA₹9 CrNDF+80.0%
Operating margin12.0%NDF+400 bps
PAT₹4 CrNDF+33.3%
PAT margin5.6%NDF+94 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
30.30
P/B
2.04
EV/EBITDA
15.41
Market Cap
219.00Cr

Profitability

ROE
7.73%
ROCE
10.50%
ROA
4.12%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
76.62%
EPS 5Y
40.00%
Revenue 3Y
-10.00%
EPS 3Y
-10.00%

Balance Sheet

Debt/Equity
0.44
Interest Coverage
2.80×
Altman Z
3.74
Book Value
59.70

Cash Flow

FCF Yield
—
FCF Positive Y
1/5
OCF
-9.00 Cr
EPS TTM
4.45

Shareholding

Promoter Hold
46.20%
Promoter Pledge
0.00%
Momentum 52W
27%

Financial History

Updated 21/10/2026

Revenue

₹ Cr
Latest: 72.0+10.8% vs prev
072.0Sep 2024: 39.0Mar 2025: 39.0Sep 2025: 65.0Mar 2026: 72.0Q2 24FY25Q2 25FY26

Net Profit

₹ Cr
Latest: 4.0+33.3% vs prev
04.0Sep 2024: 3.0Mar 2025: 2.0Sep 2025: 3.0Mar 2026: 4.0Q2 24FY25Q2 25FY26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 53. Wait for confirmation.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 rising (~11.2% over last month) — short-term momentum positive.
  • RSI(14) at 53 — sideways, no extreme reading.
  • MACD below signal but histogram contracting — bearish momentum easing.
  • 41% off 52W high · 38% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

67
RS percentile
Stage 3 Topping
1M return
-2.0%
3M return
+15.6%
6M return
+31.1%
1Y return
-24.4%
RS 1D
+8
RS 20D
+20
Sector rank
#2
Industry rank
#6
Stage evidence
  • 38.5% below the 52-week closing high after prior strength.
  • The 30-week proxy has stalled (-1.9% over 20 sessions).
  • Price has not yet confirmed a full Stage 4 downtrend.
50-DMA
price above
200-DMA
price above
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
230 observations
21 Oct 2026Value 78.56+4.08%
567288104120Sept 25Feb 26Jun 26Oct 2679
RS vs Nifty 50079

Valuation & peers

U-Score 33 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies

33U-SCORE
WATCHLIST

Fundamental score breakdown

U band · WATCHLIST
Valuation8/30
Growth19/25
Quality0/20
Balance Sheet6/15
Cash Flow0/10
Piotroski
5/9 (+3)
Penalties
-3
Raw sum
33

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

33/100 · legacy band WATCHLIST

Positive drivers

  • Fair-value margin of safety is positive at 29.1%.
  • Growth contributes 19/25 to the score.
  • Balance sheet contributes 6/15 to the score.

Main drags

  • Penalty bucket subtracts 3 points.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Cash flow is weaker at 0/10; verify the latest quarterly trend.
Sector valuation model

Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks

For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.

Blended relative
Primary lens
PE, EV/EBITDA, margin of safety, and FCF yield together.
Secondary checks
ROE/ROCE, growth, cash conversion, leverage, promoter risk.
Main risk check
One cheap metric is not enough if quality or cash flow is weak.
PE
30.3
PB
2.0
EV/EBITDA
15.4
ROE
7.7%
ROCE
10.5%
FCF Yield
—
Debt/Equity
0.4
MoS
+29.1%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
33
Previous: 33
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
+29.1%
Previous: +30.5%

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
33
33
33
33
33
32
33
33
33
33
33
33

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹77.31
-60.4% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹174.89
+29.1% MoS
PEG
0.76

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
SPEB
SME
Speb Adhesives Ltd.
Specialty Chemicals
match 134
48
28.1
16.9%
+31%
FAIR VALUE
DHARIWAL
SME
Dhariwalcorp Ltd.
Specialty Chemicals
match 133
8
35.6
11.0%
-261%
OVERVALUED
MAHICKRA
SME
Mahickra Chemicals Ltd.
Specialty Chemicals
match 132
23
54.5
10.0%
-31%
OVERVALUED
UCL
SME
Ushanti Colour Chem Ltd.
Specialty Chemicals
match 131
15
—
-0.8%
—
OVERVALUED
AMBANIORGO
SME
Ambani Orgochem Ltd.
Specialty Chemicals
match 130
6
37.5
2.6%
-493%
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-07-01T16:19:14.637Z
Management commentary snapshot

Ducol reported strong H2 FY26 consolidated revenue growth of 84.55% YoY and EBITDA growth of 206.21% YoY, driven by Bitumag integration. FY26 consolidated revenue grew 75.91% YoY to ₹136.07 Cr, with PAT up 56.68% YoY to ₹7.25 Cr, despite acquisition-related finance costs.

The company's strategic shift into non-pigment dispersions and construction chemicals via acquisitions is progressing, with Bitumag integration showing positive financial impact. While acquisition-related costs impacted standalone PAT, consolidated results reflect strong growth. Xchem acquisition nearing completion further strengthens this diversification.

Growth engines

Strategic Acquisitions

Acquisition of Bitumag Industries and Xchem Polymers to enter non-pigment dispersions, waterproofing, and construction chemicals.

International Market Expansion

Strengthening export footprint across Southeast Asia, Subcontinent, Middle East, and Africa through strategic partnerships like Qualibit and Altek International.

Cross-selling Synergies

Leveraging synergies across existing customer base to enhance wallet share and deepen customer relationships with new product offerings.

Increased Capacity Utilization

Improving utilization levels at acquired facilities to drive operating leverage and margin expansion, targeting 50%+ for Bitumag.

Capacity and execution

Bitumag Capacity

Capacity doubled to 10 Mn sq.mt. p.a. via 2nd manufacturing line commissioned post-acquisition.

Wet Dispersions Future Expansion

Planned expansion from 4,000 MTPA to 8,000 – 10,000 MTPA.

Dry Dispersions Future Expansion

Planned expansion from 15,000 MTPA to 20,000 – 25,000 MTPA.

Master Batches Future Expansion

Planned expansion from 2,000 – 3,000 MTPA to 8,000 - 10,000 MTPA.

Tailwinds

Improving Demand Conditions

Momentum driven by robust volume growth across segments and improving demand conditions.

Expanded Product Portfolio

Benefits arising from expanded product portfolio following the integration of Bitumag Industries.

Strategic Partnerships

Partnerships help accelerate market access, strengthen international presence, and broaden product offerings.

Headwinds

Acquisition-related Expenses

Profitability impacted by certain one-time acquisition-related expenses.

Increased Finance Costs

Finance costs associated with acquisition funding impacted PAT, with ₹2.20 crore in FY26.

Risk radar

Integration Risk of Acquisitions

Successful integration of acquired businesses like Xchem Polymer is crucial for realizing strategic benefits and synergies.

Debt Burden from Acquisition Financing

Additional finance costs incurred due to acquisition-related borrowings, impacting profitability until debt is repaid.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

The presentation provides both H2 FY26 vs H2 FY25 and FY26 vs FY25 comparisons. Given the significant impact of acquisitions and the full-year context, YoY comparison is most relevant to assess the growth and integration effects.

Sector KPIs management disclosed

Consolidated EBITDA Margin % (H2 FY26)

12.29% (YoY growth of 206.21%)

Consolidated EBITDA Margin % (FY26)

10.72% (YoY increase of 231 bps)

Working Capital Days (FY26)

87 days (down from 103 in FY25)

Debt to Equity (FY26)

0.44 (up from 0.30 in FY25)

Management forward view

Diversification Strategy

Continued focus on strengthening presence across waterproofing, allied construction chemicals, and adjacent specialty chemical segments.

Inorganic & Partnership Growth

Inorganic expansion will remain an important strategic lever, complemented by partnerships, distribution alliances, and collaborative market expansion.

Operational Focus

Focus on driving scale, improving operational efficiencies, increasing capacity utilization, expanding international footprint, and enhancing profitability.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Bitumag Capacity Utilization30-35% post-expansionRamp-up to targeted 50%+ utilization levels.
Xchem Acquisition IntegrationNearing completionSuccessful integration, product portfolio enhancement, and cross-selling opportunities.
Acquisition Finance CostsImpacted PAT by ₹2.20 crore in FY26Debt repayment and subsequent improvement in PAT margins.
International Market ExpansionPartnerships with Qualibit and AltekDeepening global reach through new alliances and increased export volumes.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
55Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 16th percentile of the scored universe and 12th percentile within Industrials. Main check: cash conversion is weak at 28/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
7 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
16th percentile

overall median 67 · Industrials: 12th pctile, median 68 · SME: 16th pctile, median 64

Evidence depth
Financial-only

7 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
60
acceptable · holding, pledge, alignment
Cash flow
28
weak · profit to cash conversion
Balance sheet
81
strong · leverage and solvency
Discipline
52
watch · capital discipline
Results
63
acceptable · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸OPM spread across recent quarters is 5%.

Trust risks

  • ▸Promoter holding fell 5.1%.
  • ▸Operating cash flow is negative at ₹-9 Cr.
  • ▸Only 1 years of positive FCF.
  • ▸ROE is low at 7.7%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

9 shown
Annual reportSep 2026

Sep 2026 · Shareholders meeting 27 Aug - FY26 annual report, AGM on Sept 17, 2026, and appointment of Priyanka Dharmesh Pandey as independent director.

Source: Nse

Open source ↗
AnnouncementJun 2026

Jun 2026 · Shareholders meeting 5 June 2026 - No substantive announcement content; only digital signature information.

Source: Nse

Open source ↗
Investor presentationMay 2026

May 2026 · PPT

Source: Company Ir

Open source ↗
Investor presentationMay 2026

May 2026 · Investor Presentation 20 May 2026 - Ducol reported FY26 revenue of ₹136.07 crore, PAT ₹7.25 crore, and Xchem acquisition nearing completion.

Source: Nse

Open source ↗
Annual reportMar 2026

Mar 2026 · Annual Report 2026

Source: Nse

Open source ↗
Investor presentationNov 2025

Nov 2025 · PPT

Source: Nse

Open source ↗
Investor presentationAug 2025

Aug 2025 · PPT

Source: Nse

Open source ↗
Annual reportMar 2025

Mar 2025 · Annual Report 2025

Source: Nse

Open source ↗
Investor presentationNov 2024

Nov 2024 · PPT

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.